| Product Name | Lunatic Fringe |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | LFNG antibody; Beta-1 antibody; 3-N-acetylglucosaminyltransferase lunatic fringe antibody; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase antibody; |
| Product description | This gene is a member of the fringe gene family which also includes radical and manic fringe genes. They all encode evolutionarily conserved glycosyltransferases that act in the Notch signaling pathway to define boundaries during embryonic development. While their genomic structure is distinct from other glycosyltransferases, fringe proteins have a fucose-specific beta-1,3-N-acetylglucosaminyltransferase activity that leads to elongation of O-linked fucose residues on Notch, which alters Notch signaling. This gene product is predicted to be a single-pass type II Golgi membrane protein but it may also be secreted and proteolytically processed like the related proteins in mouse and Drosophila (PMID: 9187150). Mutations in this gene have been associated with autosomal recessive spondylocostal dysostosis 3. Multiple transcript variants encoding different isoforms |
| Immunogen | The antiserum was produced against synthesized peptide derived from human LFNG. AA range:121-170 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:500-1:2000 |
|
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml |
| Alternative Names | LFNG antibody Beta-1 antibody 3-N-acetylglucosaminyltransferase lunatic fringe antibody O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase antibody |
|---|---|
| Molecular Weight(MW) | 42 kDa |
| SwissProt ID | Q8NES3 |
|---|
| Positive Control | Kidney, |
|---|---|
| Application Notes | WB:1:500-1:2000 |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
